Literature DB >> 8574058

The role of glucagon in the gastric hyperdynamic circulation of cirrhotic portal hypertensive rats.

T Yoshida1, S Kitano, M Kobayashi, Y Mitarai, T Bandoh, K Shuto.   

Abstract

The role of glucagon as a mediator of gastric hyperdynamic circulation, induced by carbon tetrachloride (CCl4), was assessed in cirrhotic rats. A selective elimination of pancreatic glucagon from the circulation was achieved by the intravenous infusion of a glucagon antiserum. Gastric blood flow was measured by laser-Doppler flowmetry. The glucagon antiserum had no effect on the blood flow in the stomach in control rats, while in cirrhotic portal hypertensive rats, the glucagon antiserum significantly reduced gastric blood flow (30%). The glucagon antiserum did not completely exclude the gastric hyperdynamic state in the cirrhotic rats. It would thus appear that glucagon contributes to a portion of the gastric hyperdynamic circulation associated with cirrhotic portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574058     DOI: 10.1007/bf00311757

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  22 in total

1.  Decreased arteriovenous flow resistance in the left gastric venous area in cirrhotic patients.

Authors:  N Koyanagi; K Inokuchi; S Nakayama; H Sakata; K Beppu
Journal:  Eur J Clin Invest       Date:  1981-10       Impact factor: 4.686

2.  Esophageal varices produced in dogs.

Authors:  H Sakata; K Inokuchi; K Nagamine; N Koyanagi
Journal:  Jpn J Surg       Date:  1985-01

3.  Increased blood flow through the portal system in cirrhotic rats.

Authors:  J Vorobioff; J E Bredfeldt; R J Groszmann
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

4.  The relationship between prostacyclin activity and pressure in the portal vein.

Authors:  G Hamilton; R C Phing; R A Hutton; P Dandona; K E Hobbs
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

5.  Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats.

Authors:  J W Kiel; V Pitts; J N Benoit; D N Granger; A P Shepherd
Journal:  Am J Physiol       Date:  1985-02

6.  Development of erosive gastritis in a canine model of esophageal varices.

Authors:  K Nagamine; K Inokuchi; H Sakata; K Beppu; N Koyanagi; K Sugimachi
Journal:  Jpn J Surg       Date:  1986-05

7.  Hemodynamic and morphological changes in the stomach of portal hypertensive rats.

Authors:  S Kitano; K Inokuchi; K Sugimachi; N Koyanagi
Journal:  Eur Surg Res       Date:  1981       Impact factor: 1.745

8.  Morphology of gastric microcirculation in cirrhosis.

Authors:  M Hashizume; K Tanaka; K Inokuchi
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

9.  Production of anti-glucagon sera with a C-terminal fragment of pancreatic glucagon.

Authors:  K Imagawa; T Nishino; S Shin; S Uehata; E Hashimura; C Yanaihara; N Yanaihara
Journal:  Endocrinol Jpn       Date:  1979-02

10.  Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.

Authors:  J V Sitzmann; G B Bulkley; M C Mitchell; K Campbell
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.